Stock NXG NEXGENRX INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages NexgenRx Inc.

Equities

NXG

CA65337X1042

Market Closed - Toronto S.E.
Other stock markets
 20:11:09 30/04/2024 BST 		5-day change 1st Jan Change
0.22 CAD -.--% Intraday chart for NexgenRx Inc. -.--% -.--%
04-05 NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors
NEXGENRX Inc Announces Declaration of Dividend, Payable on or Before January 4, 2024
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
NexgenRx Inc. Announces Declaration of Dividend in Respect of All of Its Outstanding Common Shares , Payable on or Before June 30, 2023
NexgenRx's Q1 Profit Falls, Revenue Rises
NexgenRx Inc. Appoints Dave Bennett as New Director
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
NexgenRx Swings to Loss in Q4
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
NexgenRx Inc. Announces Dividend on its outstanding common shares, payable on or Before October 10, 2022
NexgenRx Announced Q2 2022 Financial Results
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
NexgenRx Inc. Announces Dividend, Payable on February 4, 2022
NexgenRx Third-Quarter Profit Falls 15% on Higher Spending
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NXG Stock
  4. News NexgenRx Inc.
  5. Other languages